During the COVID-19 pandemic, telemedicine proved to be a vital channel for supporting patients and reducing the risks of in-person medical care. Telemedicine for elderly diabetes patients had many benefits, but also posed some challenges. Read more
A major genetic study has identified more regions of the genome linked to type 2 diabetes-related traits as a result of including multi-ethnic participants than if the research had been conducted only in Europeans, the researchers say. Previously, almost 90% of this type of genetic research had been conducted in Europeans. Read more
Abdominal obesity, also known as central obesity or central adiposity, has been associated with higher risk for many health conditions, including insulin resistance, diabetes, high blood pressure and heart conditions. A recent study looked at how fat distribution really impacts these conditions. Read more
Treatment-resistant bipolar depression may respond to the diabetes drug metformin, researchers say. A recent trial found that metformin treatment reversed insulin resistance in 50% of patients, which was associated with an improvement of the patients’ bipolar depressive symptoms. Read more
Pharma company Eli Lilly recently announced results of clinical trials for their new diabetes drug, Tirzepatide. The drug acts by mimicking the functions of incretin hormones, and would be a new type of medication to treat type 2 diabetes. It shows promise for improving blood glucose levels and helping achieve weight reduction. Read more
With the prevalence of type 2 diabetes increasing worldwide, research into the need to prevent or at least delay the development of the condition is ongoing worldwide. A new analysis underscores the urgency of delaying diabetes onset, finding that developing type 2 at a younger age is associated with increased risk of developing dementia. Read […]
Long-term use of the common diabetes drug metformin use may have a protective effect on breast cancer risk for women with type 2 diabetes, researchers say. However, the effect of metformin depends on the breast cancer subtype. Read more
People with diabetes who experienced difficulty falling or staying asleep were almost 90% more likely to die of any cause over the next nine years than people who did not have diabetes or sleep problems, according to a recent study published by the Journal of Sleep Research. Read more
Researchers say a drug combination that can contribute to weight management, cagrilintide and semaglutide, has shown effectiveness in bodyweight reduction, even without lifestyle, diet, physical activity changes or surgery. Read more
Transitioning from pediatric to adult-oriented care for type 1 diabetes is challenging for many young patients. Researchers found that adolescents with type 1 diabetes who visited with a certified diabetes educator or used a continuous glucose monitor (CGM) before transferring to adult care experienced a shorter gap in care, and potentially a reduced risk of […]
Uncontrolled gestational diabetes can contribute to poor neonatal outcomes such as increased birth weight, macrosomia, and neonatal hypoglycemia. On the other hand, aggressive glucose control may lead to small-for-gestational-age infants. Fetal size is used to guide the management of gestational diabetes; can using ultrasounds guide more accurate treatment decisions? Read more
According to the International Diabetes Federation, almost 80% of the estimated 463 million adults in the world who have diabetes live in low and middle income countries. A study of diabetes treatment in 55 of these low and middle income countries found that many people with diabetes were unaware that they had the condition, and […]
The FDA has cleared The Bigfoot Unity AI Diabetes Management System by Bigfoot Biomedical, an artificially intelligent insulin pen cap, for use in type 1 and type 2 diabetes patients aged 12 or older. The device has the potential to make insulin dosing much less burdensome for many patients. Read more
Researchers have devised a new potential type 1 diabetes vaccine that might be able to stop or slow the destruction of insulin-producing beta cells. The Swedish researcher developed a vaccine made from glutamic acid decarboxylase (GAD), a protein anchored to the surface of beta cells that many people with type 1 diabetes form antibodies against. […]
A new study examined what motivates type 2 diabetes patients’ preferences for either once-daily oral or once-weekly injectable medication. They found that initially, diabetes patients expressed a preference for the once-daily oral medication at approximately 3:1. However, many patients had a different opinion after learning more about the advantages and disadvantages of the once-weekly shot. […]
Medtronic has received two new European approvals for their diabetes monitoring and management devices: for expanded functionality of the InPen, a connected insulin pen designed for users requiring multiple daily injections, and for the Guardian 4 sensor, which can be used either as a standalone continuous glucose monitor or in tandem with the InPen or […]
A study that looked at the effect pain associated with diabetic polyneuropathy has on heart-damaging vascular events and mortality found that patients who experience painful are at increased risk. They found that when patients experience pain it can lead to more complications than for patients that are not experiencing pain. Read more
Provention Bio has announced that the FDA’s advisory committee voted 10-7 that the benefits outweigh the risks of their drug candidate teplizumab, which is designed to delay the development of type 1 diabetes. The committee based its decision on safety and efficacy data from TN-10 Study in which a single 14-day course of teplizumab delayed […]
Functional decline is the loss of mental or physical abilities that often comes with age or various health conditions. It has been established that diabetes is associated with faster physical functional decline. Now, researchers say that prediabetes, too, is associated with faster physical decline, and more aggressive treatment of prediabetes can reduce or delay physical […]
Ascensia Diabetes Care, a company that offers various tools for diabetes management, is adding an online platform that connects to any blood glucose monitoring system and will store, track and analyze the collected data. The platform, called GlucoContro.online, automatically shares the findings with patients, their caregivers and healthcare teams. Read more